# OnCo record pentixapharm (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/pentixapharm/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "pentixapharm" ;
  schema:name "Pentixapharm"@en ;
  schema:alternateName "Pentixapharm Holding AG"@en, "Pentixapharm AG"@en ;
  schema:description "Pentixapharm is a German company making radioactive medicines that home in on a protein called CXCR4, which sits on the surface of many blood cancer cells. One version shows up on a PET scan; another carries radiation, and the company plans to test it as a way to clear the bone marrow before a stem cell transplant in acute myeloid leukaemia and myeloma."@en ;
  schema:url <https://onco.cc/companies/pentixapharm/>, <https://www.pentixapharm.com/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://www.pentixapharm.com/>, <https://www.pentixapharm.com/about-us>, <https://www.pentixapharm.com/investors>, <https://live.deutsche-boerse.com/nachrichten/EQS-News-Pentixapharm-Reports-First-Quarter-2026-Results-and-Highlights-Clinical-and-Regulatory-Momentum-9b4e8771-48ad-4d31-94f2-6cd7d63b567e> ;
  schema:addressCountry "DE" ;
  onco:cancers <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/multiple-myeloma/> ;
  onco:sections <https://onco.cc/fronts/radiopharma/>, <https://onco.cc/fronts/imaging/> ;
  onco:technologies <https://onco.cc/technologies/radioligand-therapy/> ;
  onco:targets <https://onco.cc/targets/cxcr4/> .